Amphetamine Sulfate Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Amphetamine Sulfate Tablets
To view the Notice from the Expert Committee that posted in conjunction with this accelerated revision
1 DEFINITION
Amphetamine Sulfate Tablets contain NLT 93.0% and NMT 107.0% of the labeled amount of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄].
2 IDENTIFICATION
A. Melting Range or Temperature 〈741〉, Procedures: Class I
Sample: Nominally 50 mg of amphetamine sulfate from a suitable quantity of powdered Tablets
Analysis: Macerate the Sample with 10 mL of water for 30 min and filter into a small flask. To the filtrate add 3 mL of 1 N sodium hydroxide. Cool to 10°–15°, add 1 mL of a mixture of absolute ether and benzoyl chloride (2:1), insert the stopper, and shake well for 3 min. Filter the precipitate, wash with 15 mL of cold water, and recrystallize twice from diluted alcohol. Dry the residue at 80° for 2 h.
Acceptance criteria: The crystals of the benzoyl derivative of amphetamine melt between 131° and 135°.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Solution A: 14 mL of glacial acetic acid in 100 mL of water
Mobile phase: Dissolve 1.1 g of sodium 1-heptanesulfonate in 525 mL of water. Add 25 mL of Solution A and 450 mL of methanol. Adjust with glacial acetic acid to a pH of 3.3 ± 0.1.
Standard solution: 0.3 mg/mL of USP Dextroamphetamine Sulfate RS in 0.12 N phosphoric acid
Sample solution: Nominally 0.3 mg/mL of amphetamine sulfate from Tablets prepared as follows. Finely powder Tablets (NLT 20). Transfer a suitable amount of the powdered Tablets to a suitable volumetric flask. Add 80% of the flask volume of 0.12 N phosphoric acid, and sonicate for 15 min. Dilute with 0.12 N phosphoric acid to volume. Pass through a membrane filter of 0.5-µm pore size, discarding the first 20 mL of the filtrate.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; 10-µm packing L1
Flow rate: 2 mL/min. [Note—Alternatively, a 4.6-mm × 25-cm column with 5-µm packing L1 may be used with a flow rate of 1 mL/min.]
Injection volume: 50 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 3
Relative standard deviation: NMT 1.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄] in the portion of Tablets taken:
Result = (rᵤ/rₛ) × (Cₛ/Cᵤ) × 100
rᵤ = peak response of amphetamine from the Sample solution
rₛ = peak response of dextroamphetamine from the Standard solution
Cₛ = concentration of USP Dextroamphetamine Sulfate RS in the Standard solution (mg/mL)
Cᵤ = nominal concentration of amphetamine sulfate in the Sample solution (mg/mL)
Acceptance criteria: 93.0%–107.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
Test 1
Medium: Water; 500 mL
Apparatus 1: 100 rpm
Time: 45 min
Solution A: 14 mL of glacial acetic acid in 100 mL of water
Mobile phase: 1.1 g of sodium 1-heptanesulfonate in 575 mL of water. Add 25 mL of Solution A, and 400 mL of methanol. Adjust with glacial acetic acid to a pH of 3.3 ± 0.1.
Standard solution: USP Dextroamphetamine Sulfate RS in Medium having a known concentration of USP Dextroamphetamine Sulfate RS similar to the concentration expected in the sample.
Sample solution: Pass a portion of the solution under test through a suitable filter.
Chromatographic system
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; 10-µm packing L1
Flow rate: 1 mL/min
Injection volume: 500 µL
System suitability
Sample: Standard solution
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄] dissolved:
Result = (rᵤ/rₛ) × Cₛ × V × (1/L) × 100
rᵤ = peak response of amphetamine from the Sample solution
rₛ = peak response of dextroamphetamine from the Standard solution
Cₛ = concentration of USP Dextroamphetamine Sulfate RS in the Standard solution (mg/mL)
V = volume of Medium, 500 mL
L = label claim (mg/Tablet)
Tolerances: NLT 75% (Q) of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄] is dissolved.
Test 2
If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: Water; 500 mL, deaerated if necessary
Apparatus 1: 100 rpm
Time: 15 min
Solution A: 5 mL of trifluoroacetic acid in 950 mL of water. Adjust with ammonium hydroxide to a pH of 2.2. Add 50 mL of acetonitrile.
Solution B: Acetonitrile
Mobile phase: See Table 1 (below).
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0.0 | 95 | 5 |
| 8.0 | 79 | 21 |
| 8.1 | 0 | 100 |
| 12.0 | 0 | 100 |
| 12.1 | 95 | 5 |
| 15.0 | 95 | 5 |
Standard solution: (L/500) mg/mL of USP Dextroamphetamine Sulfate RS in Solution A, where L is the label claim in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable filter.
Chromatographic system
Mode: LC
Detector: UV 257 nm
Column: 4.6-mm × 15-cm; 2.6-μm packing L1
Column temperature: 40°C
Flow rate: 1 mL/min
Injection volume: 50 µL
System suitability
Sample: Standard solution
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Result = (rᵤ/rₛ) × Cₛ × V × (1/L) × 100
Tolerances: NLT 80% (Q) of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄] is dissolved.
Test 3
If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3.
Medium: Water; 500 mL
Apparatus 1: 100 rpm
Time: 20 min
Solution A: 14 mL of glacial acetic acid in 100 mL of water
Mobile phase: Dissolve 1.1 g of sodium 1-heptanesulfonate in 525 mL of water. Add 25 mL of Solution A and 450 mL of methanol. Adjust with glacial acetic acid to a pH of 3.3.
Diluent: 0.12 N phosphoric acid in water
Standard stock solution: 0.10 mg/mL of USP Dextroamphetamine Sulfate RS in Diluent. Sonicate to dissolve, if necessary.
Standard solution: (L/500) mg/mL of USP Dextroamphetamine Sulfate RS from the Standard stock solution in water, where L is the label claim in mg/Tablet
Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size, discarding an appropriate volume of filtrate so that a consistent result can be obtained.
Chromatographic system
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; 10-μm packing L1
Column temperature: 35°C
Flow rate: 1.5 mL/min
Injection volume: 200 µL
Run time: NLT 2 times the retention time of amphetamine
System suitability
Sample: Standard solution
Tailing Factor: NMT 3.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Result = (rᵤ/rₛ) × Cₛ × V × (1/L) × 100
Tolerances: NLT 80% (Q) of amphetamine sulfate [(C₉H₁₃N)₂·H₂SO₄] is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers. Store at controlled room temperature.
Labeling: When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
USP Reference Standards 〈11〉:
USP Dextroamphetamine Sulfate RS

